MoffittRadOnc
@moffittradonc
Product of your friendly local Moffitt Radiation Oncology Residents. Highlighting departmental news, successes, research, events.
ID: 1162468887939702785
https://bit.ly/2OZkoEg 16-08-2019 21:01:48
544 Tweet
936 Takipçi
485 Takip Edilen
Congrats to our graduating residents ! I am so excited to see where your careers take you — remember you always have a home at Moffitt MoffittRadOnc Kosj Yamoah MD, PhD Jessica Frakes Casey Liveringhouse marisandoval1589 Ammoren Dohm MD #radonc
End of an era! Had a great time celebrating #radonc residency graduation 🎓 with Wake Forest Radiation Oncology Residency Program, family, and friends. Looking forward to my next steps Moffitt Cancer Center MoffittRadOnc
A research team at MoffittRadOnc led by Tom Dilling publishes the largest series evaluating Surgery and SBRT for stage I SCLC. The report contains valuable data about adjuvant chemotherapy and PCI for this population. #radonc sciencedirect.com/science/articl…
Congratulations to both of our chief residents on passing their Medical Physics and RadBio boards! 🔥😬☢️ JM Bryant, MD Ruben J. Cruz, MD Jessica Frakes Stephen Rosenberg, MD Moffitt Cancer Center
Kamran Ahmed giving a great summary of the Phase II Study of Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in the Management of HER2+ Breast Leptomeningeal Disease. A collaborative effort with Peter Forsyth Moffitt Cancer Center and Priya Kumthekar. #snoasco24
Radiation therapy followed by intrathecal trastuzumab and pertuzumab for HER2+ breast leptomeningeal disease is safe with initial intracranial control results that appear encouraging. ja.ma/4fAaPDY Kamran Ahmed Moffitt Cancer Center
Our chair, Dr. Kosj Yamoah, opens up our departmental FORT Retreat meeting! 🧬 Kosj Yamoah MD, PhD Moffitt Cancer Center Kamran Ahmed
Tomorrow at #WCLC24: Moffitt’s Thomas Dilling, MD (Tom Dilling) presents a machine learning analysis of cardiac doses and survival in NSCLC chemoradiotherapy during the e-poster session. ⏰: 9/7 Learn more ➡️ bit.ly/4e4CStS